 GlaxoSmithKline PLC said a Chinese court found the drug maker's local subsidiary guilty of bribery and fined the company nearly $500 million, capping a scandal that has shaken China's pharmaceutical industry.. Five of the company's managers, including Mark Reilly, its former top China executive, were convicted of bribery-related charges and received suspended prison sentences, a Glaxo spokesman said Friday.. Glaxo...
  